Who makes Cholografin Meglumine?

Cholografin Meglumine is developed by Bracco.

What development phase is Cholografin Meglumine in?

Cholografin Meglumine is FDA-approved (marketed).

What is the generic name of Cholografin Meglumine?

IODIPAMIDE SODIUM is the generic (nonproprietary) name of Cholografin Meglumine.

Last reviewed 2026-04-20 · How we verify

Cholografin Meglumine (IODIPAMIDE SODIUM)

Bracco · FDA-approved approved Small molecule Quality 10/100

At a glance

Generic name	IODIPAMIDE SODIUM
Sponsor	Bracco
Drug class	Radiographic Contrast Agent
Modality	Small molecule
Therapeutic area	Gastroenterology
Phase	FDA-approved
First approval	1954

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary Sclerosing Cholangitis: Value of Computerized Tomographic Cholangiography and Intraductal Volumetric Measurement in Determining the Prognosis (Phase 2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cholografin Meglumine CI brief — competitive landscape report
Cholografin Meglumine updates RSS · CI watch RSS
Bracco portfolio CI